Evidence map›Paper›PMID 39400524›Full record

ArticleMolecular genetics & genomic medicine2024

Identification of Pathogenic Copy Number Variants in Mexican Patients With Inherited Retinal Dystrophies Applying an Exome Sequencing Data-Based Read-Depth Approach.

Gerardo E Fabian-Morales, Vianey Ordoñez-Labastida, Froylan Garcia-Martínez, Luis Montes-Almanza, Juan C Zenteno

Abstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gerardo E Fabian-MoralesDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.ORCID https://orcid.org/0000-0003-1501-3210
Vianey Ordoñez-LabastidaDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Froylan Garcia-MartínezDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Luis Montes-AlmanzaDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Juan C ZentenoDepartment of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.ORCID https://orcid.org/0000-0002-9716-8146

Funding

Velux Stiftung 1860
6 · The paper itself

Abstract

backgroundRetinal dystrophies (RDs) are the most common cause of inherited blindness worldwide and are caused by genetic defects in about 300 different genes. While targeted next-generation sequencing (NGS) has been demonstrated to be a reliable and efficient method to identify RD disease-causing variants, it doesn't routinely identify pathogenic structural variant as copy number variations (CNVs). Targeted NGS-based CNV detection has become a crucial step for RDs molecular diagnosis, particularly in cases without identified causative single nucleotide or Indels variants. Herein, we report the exome sequencing (ES) data-based read-depth bioinformatic analysis in a group of 30 unrelated Mexican RD patients with a negative or inconclusive genetic result after ES.

methodsCNV detection was performed using ExomeDepth software, an R package designed to detect CNVs using exome data. Bioinformatic validation of identified CNVs was conducted through a commercially available CNV caller. All identified candidate pathogenic CNVs were orthogonally verified through quantitative PCR assays.

resultsPathogenic or likely pathogenic CNVs were identified in 6 out of 30 cases (20%), and of them, a definitive molecular diagnosis was reached in 5 cases, for a final diagnostic rate of ~17%. CNV-carrying genes included CLN3 (2 cases), ABCA4 (novel deletion), EYS, and RPGRIP1.

conclusionsOur results indicate that bioinformatic analysis of ES data is a reliable method for pathogenic CNV detection and that it should be incorporated in cases with a negative or inconclusive molecular result after ES.

Indexed as

DNA Copy Number VariationsExome SequencingRetinal DystrophiesAdolescentAdultChildComputational BiologyFemaleHumansMaleMexicoMiddle AgedSequence DeletionYoung Adultcopy number variationdeletionexome sequencingretinal dystrophy

Identifiers

PMID39400524
PMCPMC11472028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.